Why FMC Stock Is Falling: A Bear's Case in 2026

FMC Corporation faces a perfect storm of headwinds that has sent its stock tumbling throughout 2025 and into 2026, and the falling trajectory shows few signs of reversal. The agricultural sciences company, which develops and distributes crop protection chemicals including insecticides, herbicides, and fungicides across North America, Latin America, Europe, the Middle East, Africa, and Asia, has become a textbook example of how quickly market conditions can turn against even established businesses.

Deteriorating Fundamentals: From Earnings Misses to Credit Downgrades

The most recent quarterly results confirmed investors’ worst fears about the company’s operational health. FMC reported adjusted earnings of just $1.20 per share in the fourth quarter—a stunning 33% collapse compared to $1.79 per share in the same period a year earlier. Revenue disappointment accompanied this earnings disaster, with the company posting $1.08 billion against an analyst estimate of $1.15 billion, representing a 6% shortfall and an alarming 11.5% year-over-year revenue decline.

What makes this particularly troubling for long-position holders is the trajectory of analyst expectations. Rather than recovering, earnings estimates have been slashed aggressively. In just the past two months, consensus estimates dropped by 246.67%, with the current outlook now pointing to negative earnings of -$0.22 per share for the current period—a -222.2% deterioration relative to the prior-year quarter. Revenue forecasts tell a similarly grim story, with projections calling for an 8.5% decline to $723.9 million.

The credit rating agencies took notice of this falling performance. Major institutions including S&P Global, Fitch, and Moody’s downgraded FMC to junk status, citing weak financial metrics and unsustainable debt levels relative to declining cash flows. In response, the company slashed its annual dividend by $250 million—a dramatic acknowledgment that the current business model cannot support previous distribution levels. For income-focused investors, this move crystallized the severity of the company’s predicament.

Technical Signals Align with the Bearish Outlook

The chart patterns tell a story of sustained investor pessimism that extends beyond quarterly earnings volatility. FMC stock is trading decisively below its 200-day moving average—a line sloping downward and serving as resistance to any potential recovery attempts. More concerning for contrarian bulls, the stock has experienced a “death cross,” the technical trigger where the 50-day moving average crossed below the 200-day moving average.

These technical formations are rarely accidental. They typically reflect a fundamental shift in investor sentiment from accumulation to distribution. The stock has fallen nearly 60% over the past year alone, substantially underperforming major indices. To turn this technician’s nightmare around, FMC would need not just stabilization but an outsized move upward—the kind that would require meaningful positive surprises in earnings or a dramatic reversal in agricultural market conditions.

Industry Headwinds Creating a Perfect Storm

The challenges facing FMC extend well beyond the company’s internal operational issues. The agricultural chemical industry itself occupies one of the worst-performing sectors in the current market environment. FMC’s industry group ranks in the bottom 23% of approximately 250 Zacks-ranked industries, and this weak industry classification creates a structural headwind to any potential stock recovery.

When individual stocks struggle within lagging industry groups, the path to outperformance becomes exponentially more difficult. Sector rotation away from agriculture, combined with competitive pressures on key portfolio products and price weakness, has created an environment where FMC cannot easily break free. Additionally, tariff pressures and elevated cost structures threaten to squeeze margins further, even as selling prices face downward pressure.

The competitive dynamics within agrochemicals have intensified, with rivals capturing market share and pressuring prices on FMC’s flagship products. This combination of commodity-like pricing pressure and rising input costs creates a margin squeeze that the company’s current revenue base cannot absorb profitably.

The Investment Implications for Risk-Averse Investors

From both fundamental and technical perspectives, FMC presents a cautionary tale rather than an opportunity. The falling earnings trajectory, combined with deteriorating credit ratings and an unfavorable industry backdrop, creates multiple layers of bearish pressure. The dividend cut signals management’s acknowledgment that prior assumptions about the business no longer hold.

For investors currently holding positions, the deteriorating outlook warrants serious consideration of whether exposure makes sense in a portfolio. For those considering entry, the current environment offers few reasons for optimism. The combination of negative growth forecasts, structural industry challenges, and technical weakness suggests that patience is the prudent strategy.

Only when the company demonstrates meaningful evidence of stabilization—including positive earnings estimate revisions, margin recovery, and a reversal in technical indicators—should investors revisit their stance on FMC stock. Until such signals emerge, this bear case appears to have considerable runway ahead.